Related Experiment Video

Updated: Jun 19, 2026

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer
09:38

Adapting 3' Rapid Amplification of CDNA Ends to Map Transcripts in Cancer

Published on: March 28, 2018

ATAD2 is a novel cofactor for MYC, overexpressed and amplified in aggressive tumors

Marco Ciró1, Elena Prosperini, Micaela Quarto

  • 1Department of Experimental Oncology, European Institute of Oncology, Milan, Italy.

Cancer Research
|October 22, 2009
PubMed

Insights

Researchers discovered ATAD2, a novel gene regulated by E2F, which enhances MYC activity. High ATAD2 expression in tumors suggests its role in aggressive cancers and links E2F and MYC pathways.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • E2F and MYC are key transcription factors regulating cell proliferation.
  • Dysregulation of these factors contributes to human cancer development.

Purpose of the Study:

  • Identify novel E2F target genes.
  • Investigate the role of ATAD2 in cancer.

Main Methods:

  • Gene expression analysis
  • Protein-protein interaction studies
  • Chromosomal mapping
  • Clinical outcome correlation

Main Results:

  • ATAD2, containing bromodomain and ATPase domains, is a novel E2F target gene.
  • ATAD2 expression is regulated by the pRB-E2F pathway and is crucial for cell cycle entry.
  • ATAD2 interacts with MYC, enhancing its transcriptional activity.
  • ATAD2 is located near MYC at chromosome 8q24, a region amplified in cancer.
  • Elevated ATAD2 expression in human tumors correlates with poor clinical outcomes in breast cancer patients.

Conclusions:

  • ATAD2 acts as a molecular link between the E2F and MYC pathways.
  • ATAD2 promotes aggressive cancer development by boosting MYC-dependent transcription.

More Related Videos

Sequence-specific Labeling of Nucleic Acids and Proteins with Methyltransferases and Cofactor Analogues12:07

Sequence-specific Labeling of Nucleic Acids and Proteins with Methyltransferases and Cofactor Analogues

Published on: November 22, 2014

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...